Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AcousticScan was an Israeli medical technology company that specialized in the development of advanced three-dimensional (3D) ultrasound imaging systems. The company's primary focus was on improving the early detection and diagnosis of breast cancer through its proprietary automated whole-breast ultrasound technology. By providing high-resolution, operator-independent 3D images, AcousticScan aimed to overcome the limitations of traditional 2D ultrasound and mammography, particularly in women with dense breast tissue. The company was acquired by GE Medical Systems (now GE Healthcare) in 2001 to bolster its global ultrasound portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AcousticScan.